SI2181990T1 - Piperidinski derivat - Google Patents

Piperidinski derivat

Info

Publication number
SI2181990T1
SI2181990T1 SI200830756T SI200830756T SI2181990T1 SI 2181990 T1 SI2181990 T1 SI 2181990T1 SI 200830756 T SI200830756 T SI 200830756T SI 200830756 T SI200830756 T SI 200830756T SI 2181990 T1 SI2181990 T1 SI 2181990T1
Authority
SI
Slovenia
Prior art keywords
piperidine derivative
piperidine
derivative
Prior art date
Application number
SI200830756T
Other languages
English (en)
Inventor
Akio Kakefuda
Kazushi Watanabe
Akio Kamikawa
Kentaro Enjo
Takashi Furutani
Minoru Yasuda
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of SI2181990T1 publication Critical patent/SI2181990T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI200830756T 2007-08-31 2008-08-28 Piperidinski derivat SI2181990T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007225378 2007-08-31
PCT/JP2008/065429 WO2009028618A1 (ja) 2007-08-31 2008-08-28 ピペリジン誘導体
EP08828181A EP2181990B1 (en) 2007-08-31 2008-08-28 Piperidine derivative

Publications (1)

Publication Number Publication Date
SI2181990T1 true SI2181990T1 (sl) 2012-10-30

Family

ID=40387332

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830756T SI2181990T1 (sl) 2007-08-31 2008-08-28 Piperidinski derivat

Country Status (20)

Country Link
US (1) US8513422B2 (sl)
EP (1) EP2181990B1 (sl)
JP (1) JP5327051B2 (sl)
KR (1) KR20100050444A (sl)
CN (1) CN101821253B (sl)
AU (1) AU2008292420A1 (sl)
BR (1) BRPI0815787A2 (sl)
CA (1) CA2696799A1 (sl)
CY (1) CY1113417T1 (sl)
DK (1) DK2181990T3 (sl)
ES (1) ES2392120T3 (sl)
HR (1) HRP20120837T1 (sl)
MX (1) MX2010002268A (sl)
PL (1) PL2181990T3 (sl)
PT (1) PT2181990E (sl)
RU (1) RU2470020C2 (sl)
SI (1) SI2181990T1 (sl)
TW (1) TW200924765A (sl)
WO (1) WO2009028618A1 (sl)
ZA (1) ZA201000917B (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5609150B2 (ja) * 2009-02-27 2014-10-22 アステラス製薬株式会社 ピペリジン誘導体
JP2012102017A (ja) * 2009-03-03 2012-05-31 Astellas Pharma Inc インドール化合物
JP2012102018A (ja) * 2009-03-03 2012-05-31 Astellas Pharma Inc アミド化合物
JP5851998B2 (ja) * 2009-10-27 2016-02-03 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 殺虫剤および殺ダニ剤としてのハロアルキル置換アミド

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116732D0 (en) 1991-08-02 1991-09-18 Fujisawa Pharmaceutical Co Indole derivatives
AU680870B2 (en) 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1998028292A1 (en) 1996-12-23 1998-07-02 Smithkline Beecham Corporation Novel piperidine containing compounds
CA2323089A1 (en) 1998-03-11 1999-09-16 Endorecherche, Inc. Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use
WO2000007576A2 (en) * 1998-08-07 2000-02-17 Endorecherche, Inc. INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE
US6787651B2 (en) 2000-10-10 2004-09-07 Smithkline Beecham Corporation Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents
MXPA03008143A (es) * 2001-03-09 2005-08-16 Johnson & Johnson Compuestos heterociclicos.
US7129225B2 (en) 2001-10-22 2006-10-31 The Research Foundation Of State University Of New York Protection against and treatment of hearing loss
AU2002360561A1 (en) 2001-12-11 2003-06-23 Sepracor, Inc. 4-substituted piperidines, and methods of use thereof
MXPA05007572A (es) 2003-01-17 2005-11-17 Threshold Pharmaceuticals Inc Tratamiento de hiperplasia prostatica benigna.
EP1787982B1 (en) 2003-04-11 2010-05-12 High Point Pharmaceuticals, LLC 11Beta-Hydroxysteroid dehydrogenase type 1 active compounds
MXPA06002018A (es) 2003-08-21 2006-05-31 Osi Pharm Inc Bencimidazolilo n-sustituidos inhibidores de c-kit.
WO2005040112A1 (en) 2003-10-14 2005-05-06 Oxagen Limited Compounds with pgd2 antagonist activity
JP2005162657A (ja) 2003-12-02 2005-06-23 Takeda Chem Ind Ltd カンナビノイド受容体調節剤
WO2005082905A1 (ja) * 2004-02-26 2005-09-09 Kyowa Hakko Kogyo Co., Ltd. 二環性複素環化合物
JP5070041B2 (ja) 2004-05-03 2012-11-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドローゲン受容体モジュレーター（ｓａｒｍｓ）としての新規インドール化合物
CA2565205A1 (en) * 2004-05-03 2005-11-24 Janssen Pharmaceutica N.V. Benzofuran derivatives as selective androgen receptor modulators (sarms)
PT1761519E (pt) * 2004-06-21 2008-07-02 Hoffmann La Roche Derivados de indole utilizados como antagonistas do receptor de histamina
EP1931658A2 (en) * 2005-09-07 2008-06-18 Plexxikon, Inc. 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds
EP1960382A1 (en) 2005-11-03 2008-08-27 ChemBridge Research Laboratories, Inc. Heterocyclic compounds as tyrosine kinase modulators
MX2008011127A (es) 2006-03-02 2008-10-31 Astellas Pharma Inc INHIBIDOR DE 17ß HSD TIPO 5.

Also Published As

Publication number Publication date
EP2181990B1 (en) 2012-08-08
EP2181990A1 (en) 2010-05-05
WO2009028618A1 (ja) 2009-03-05
US8513422B2 (en) 2013-08-20
AU2008292420A1 (en) 2009-03-05
MX2010002268A (es) 2010-03-25
RU2010112412A (ru) 2011-10-10
TW200924765A (en) 2009-06-16
JP5327051B2 (ja) 2013-10-30
EP2181990A4 (en) 2011-09-07
RU2470020C2 (ru) 2012-12-20
CN101821253B (zh) 2013-07-17
BRPI0815787A2 (pt) 2015-02-24
CN101821253A (zh) 2010-09-01
CY1113417T1 (el) 2016-06-22
HRP20120837T1 (hr) 2012-11-30
JPWO2009028618A1 (ja) 2010-12-02
US20100256189A1 (en) 2010-10-07
CA2696799A1 (en) 2009-03-05
ES2392120T3 (es) 2012-12-04
KR20100050444A (ko) 2010-05-13
PL2181990T3 (pl) 2013-01-31
ZA201000917B (en) 2011-04-28
PT2181990E (pt) 2012-10-16
DK2181990T3 (da) 2012-09-10

Similar Documents

Publication Publication Date Title
EP2120573A4 (en) DERIVATIVES OF PIPERIDINE
EP2226315A4 (en) 2-AMINOQUINAZOLINE DERIVATIVE
ZA200908298B (en) Bicycloaniline derivative
EP2213673A4 (en) PYRIDONE-SUBSTITUTED DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVE
LT2017278T (lt) Dihidropirazolopirimidinono darinys
EP2009005A4 (en) AZOLECARBOXAMIDE DERIVATIVE
EP2098517A4 (en) NEW PHENYLISOXAZOLE-3-OLDERIVATE
EP2376493A4 (en) DIHYDROPYRIMIDOPYRIMIDINE DERIVATIVE
EP2380877A4 (en) PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
HK1158189A1 (en) Morpholinopurine derivative
ZA200902002B (en) Piperidine derivatives
EP2269993A4 (en) 2-aminoquinazoline DERIVATIVE
IL206875A0 (en) Bicycloamine derivative
HK1144196A1 (en) 4-pyrimidinesulfamide derivative 4-
IL208623A0 (en) Cyclopentylacrylamide derivative
EP2163554A4 (en) PYRIMIDODIAZEPINONE DERIVATIVE
EP2157084A4 (en) 5-phenyl-3-pyridazinone derivative
EP2258697A4 (en) HYDROXYCHINOXALINCARBOXAMIDDERIVAT
IL207315A0 (en) Piperidine derivative
EP2248811A4 (en) 2-OXOCHROMENE DERIVATIVE
ZA201000917B (en) Piperidine derivative
IL212683A0 (en) Biphenylacetamide derivative
EP2228362A4 (en) 4-HYDROXYPHENYLALKYLAMINE DERIVATIVE
EP2184272A4 (en) PIPERAZINE DERIVATIVE
EP2328892A4 (en) Oxo-tetrahydrofuran-2-YL-benzimidazole derivative